HeartSciences Inc.
HSCS Healthcare Medical Devices
HeartSciences Inc.’s revenue for fiscal 2026 (year ended April 2026) was $4,300.00, down 2.27% from fiscal 2025. In the quarter to July 2026, revenue fell 46.2%, EPS grew 45.6% and free cash flow grew 18.2%, each against the same quarter a year earlier.
Follow HSCS
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
0.03 | 1.66 | 3.40 | 1.95 |
+8 more quarters Free account |
Inventory |
0.40 | 0.66 | 0.66 | 0.66 | |
Other current assets |
0.04 | 0.04 | 0.04 | 0.26 | |
Total current assets |
0.81 | 2.58 | 5.10 | 3.79 | |
Property, Plant, Equpment (Net) |
0.03 | 0.04 | 0.05 | 0.05 | |
Software (Capitalized) |
0.99 | 0.72 | 0.46 | 0.20 | |
Goodwill and Intangible Assets (Total) |
1.66 | 1.66 | 1.66 | 1.63 | |
Total non-current assets |
2.93 | 2.68 | 2.46 | 2.20 | |
Total Assets |
3.74 | 5.26 | 7.55 | 6.00 | |
Notes Payable |
3.72 | 3.62 | 3.10 | 0.50 | |
Accounts Payable |
1.02 | 0.32 | 0.41 | 0.32 | |
Accrued Expenses |
0.26 | 0.43 | 0.34 | 0.31 | |
Other current liabilities |
0.18 | 0.02 | 0.08 | 0.15 | |
Total current liabilities |
5.63 | 4.86 | 4.27 | 1.57 | |
Long Term Debt (Total) |
— | — | 0.42 | — | |
Total non-current liabilities |
0.14 | 0.18 | 0.63 | 0.25 | |
Total liabilities |
5.77 | 5.04 | 4.90 | 1.81 | |
Additional Paid In Capital |
86.40 | 85.49 | 85.17 | 84.71 | |
Preferred Stock (Total) |
0.00 | 0.00 | 0.00 | 0.00 | |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(88.44) | (85.27) | (82.52) | (80.53) | |
Common Equity (Total) |
(2.03) | 0.23 | 2.65 | 4.18 | |
Shareholders Equity (Total) |
(2.03) | 0.23 | 2.65 | 4.18 | |
Shareholders Equity and Liabilities (Total) |
3.74 | 5.26 | 7.55 | 6.00 | |
Shares (Common) |
3.91 | 3.19 | 3.18 | 3.07 | |
Shares (Preferred) |
0.81 | 0.91 | 0.92 | 0.96 | |
Shareholders Equity (Tangible) |
(3.70) | (1.43) | 0.99 | 2.55 | |
Net Debt |
(0.03) | (1.66) | (2.98) | (1.95) | |
Total Debt |
— | — | 0.42 | — |